跳到正文
原文
Medical Xpress·· 55 分钟前AI 评分60

高血糖为糖尿病患者提供一种实验性血糖控制植入物

High blood sugar powers an experimental implant that helps improve glucose control in diabetes

AI 导读

研究人员开发了一种名为NeuroAxis的实验性植入物,利用血糖发电并实时监测代谢变化。该植入物通过刺激迷走神经调节血糖和炎症,改善了糖尿病患者的血糖控制和胰岛素敏感性。

正文
Sugar-powered implant improves blood sugar control in rats with diabetes
Design of NeuroAxis for closed-loop modulation of metabolic disorders. Credit: Nature (2026). DOI: 10.1038/s41586-026-11251-7

High blood sugar, a major problem in type 2 diabetes, could become part of the solution in monitoring the disease. Researchers have developed an experimental implant called NeuroAxis that utilizes a glucose fuel cell to harvest energy and sense metabolic fluctuations in real time.

Both type 1 and type 2 diabetes do more than raise blood sugar. They also trigger chronic inflammation, which can disrupt the neuroimmune axis, the communication network between the nervous and immune systems. Electroceuticals that stimulate the autonomic nervous system could help bring this inflammation under control. However, existing systems lack a way to sense the body's metabolism in real time and use that feedback to restore the balance between the immune and metabolic systems. Also, they need external batteries or wireless charging to run.

NeuroAxis turns this limitation on its head by using glucose itself to power the implant. A built-in fuel cell converts sugar in the surrounding tissue fluid into electricity, allowing the device to monitor glucose levels and run without external batteries or wireless charging. When glucose levels rise dangerously high, it automatically sends electrical pulses to the vagus nerve, activating the body's natural mechanisms for regulating metabolism and inflammation.

The findings are published in Nature.

Sugar-powered implant improves blood sugar control in rats with diabetes
Schematic of the design and components of the NeuroAxis. Credit: Nature (2026). DOI: 10.1038/s41586-026-11251-7

Artificially reinstating the neuroimmune axis

The vagus nerve acts as the body's primary communication superhighway between the brain and major internal organs, including the liver, pancreas, gut and immune system. When blood sugar rises, signals along the vagus nerve tell the liver to stop releasing excess glucose and instruct the pancreas to secrete insulin. It also releases chemical signals that bind to immune cells and act as natural suppressants against chronic inflammation.

Diabetes and related metabolic disorders affect more than 14% of adults worldwide. Besides high blood sugar, these conditions often come with long-lasting inflammation and poor coordination between the nervous, immune and metabolic systems. This can lead to the vagus nerve not being able to perform its regulatory tasks.

The NeuroAxis implant helped overcome this issue by acting as an artificial neuroimmune axis that directly interfaces with the vagus nerve to rebuild this broken loop.

Sugar-powered implant improves blood sugar control in rats with diabetes
Longitudinal nonfasting blood glucose levels for rats with type 2 diabetes over six weeks. Credit: Nature (2026). DOI: 10.1038/s41586-026-11251-7

Sugar-powered blood sugar manager

The device runs on a tiny glucose fuel cell containing gold and platinum nanoparticles. The gold nanoparticles act like enzymes, speeding up the conversion of glucose into gluconate and producing the electricity needed to power the implant's control system. Meanwhile, the platinum nanoparticles help drive the oxygen reaction that completes the process.

As blood sugar levels rise or fall, the fuel cell's output voltage changes in direct proportion, allowing an integrated flexible circuit board to measure the voltage every 30 minutes and track glucose levels in real time. If blood sugar remained elevated for five consecutive readings (2.5 hours), the device delivered three minutes of gentle electrical stimulation directly to the vagus nerve.

After the functionality and safety checks, they implanted NeuroAxis in rat models with type 1 and type 2 diabetes. In rats with type 1 diabetes, the treatment promoted pancreatic beta-cell growth and increased total beta-cell mass, helping restore insulin production. In rats with type 2 diabetes, NeuroAxis brought blood sugar levels close to normal within just two weeks while also improving insulin sensitivity.

The benefits went beyond blood sugar control, with the animals showing less inflammation and reduced body and liver fat. Even after the implant switched to standby around the second week and didn't actively stimulate the nerve, improvements lasted through the six-week study.

The results point to a promising new way of treating metabolic disorders by creating an artificial neuroimmune axis that can regulate communication between different organs on its own. However, the researchers say the technology needs further improvements in biofuel cell stability and threshold setting before it can be used over longer periods.

Written for you by our author Sanjukta Mondal, edited by Sadie Harley, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You'll get an ad-free account as a thank-you.

Publication details

Weijun Xiu et al., A glucose-powered artificial neuroimmune axis for metabolic control, Nature (2026). DOI: 10.1038/s41586-026-11251-7

Journal information: Nature

Who's behind this story?

Sanjukta Mondal

Sanjukta Mondal

Master's in Chemistry. Freelance science journalist and communicator. Published in Chemistry World, BioSpace, and The Hindu. Full profile →

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

© 2026 Science X Network

Citation: High blood sugar powers an experimental implant that helps improve glucose control in diabetes (2026, November 20) retrieved 20 November 2026 from https://medicalxpress.com/news/2026-11-high-blood-sugar-powers-experimental.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com